PRESTIGE CONSMR (PBH)
(Real Time Quote from BATS)
$71.88 USD
+0.14 (0.20%)
Updated Apr 30, 2024 03:23 PM ET
2-Buy of 5 2
B Value D Growth F Momentum C VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
PBH 71.88 +0.14(0.20%)
Will PBH be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for PBH based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for PBH
PBH vs. ABT: Which Stock Is the Better Value Option?
Prestige Consumer Healthcare (PBH) Earnings Expected to Grow: What to Know Ahead of Q4 Release
PBH: What are Zacks experts saying now?
Zacks Private Portfolio Services
Here's Why You Should Retain Prestige Consumer (PBH) Stock Now
Here's Why Prestige Consumer Healthcare (PBH) is a Strong Value Stock
Here's Why Prestige Consumer Healthcare (PBH) is a Strong Value Stock
Other News for PBH
PointsBet Holdings Ltd. (PBTHF) Receives a Buy from Jefferies
Premium Brands Announces Q1 2024 Results Date
Prestige Consumer Healthcare Inc. to Release Fiscal 2024 Fourth Quarter and Year-End Earnings Results
PointsBet Announces Generous Capital Return
PointsBet Announces Cash Return to Shareholders